CN Patent

CN119072304A — 用于治疗cns相关障碍的神经活性类固醇

Assigned to Sage Therapeutics Inc · Expires 2024-12-03 · 1y expired

What this patent protects

本发明涉及用化合物(1)和另外的抗抑郁药的组合，随后继续施用另外的抗抑郁药在有需要的受试者中治疗重度抑郁障碍(MDD)或产后抑郁症(PPD)的方法。

USPTO Abstract

本发明涉及用化合物(1)和另外的抗抑郁药的组合，随后继续施用另外的抗抑郁药在有需要的受试者中治疗重度抑郁障碍(MDD)或产后抑郁症(PPD)的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN119072304A
Jurisdiction
CN
Classification
—
Expires
2024-12-03
Drug substance claim
No
Drug product claim
No
Assignee
Sage Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.